Leading Innovation in the Life Sciences
New York Bio Connect aims to simplify and amplify the state and city’s life sciences ecosystem, organizing opportunities from Manhattan to Buffalo to position students, entrepreneurs, investors, policy makers, and established industry leaders for success.
Funding
Investing in innovation
Careers
Your future starts here
The Latest
Ognomy Sleep Raises $20M Series A to Expand Virtual Sleep Apnea Care
Ognomy Sleep, a leading virtual sleep medicine platform transforming access to diagnosis and treatment for obstructive sleep apnea, announced the closing of a $20 million Series A financing round led by Catalyst Investors, with participation from Blue Heron Capital. The round also included new and follow-on investments from Impellent Ventures, LaunchNY, Excell and Upstate Biotech…
Claude Science, an AI workbench for scientists, is now available
Scientific research is often tedious. Researchers must work across dozens of databases, each with their own schema, contend with file formats that require bespoke data pipelines and viewers, and transition between a roster of tools: PubMed, Jupyter, R, a cluster terminal, and more. Claude Science brings these fragmented tools into a single research environment where…
Upstate helps lead global trial that could change heart failure care
Upstate Medical University has enrolled the first patient in a landmark international clinical trial that could reshape treatment for heart failure patients with cardiomyopathy and electrical conduction issues, with Upstate cardiologist Jorge E. Romero serving as one of two principal investigators leading the study worldwide. Upstate will enroll three more patients later this month. The…
HHS and FDA propose clinical trial reforms to expedite drug development
The US Food and Drug Administration (FDA) is seeking comments on a pilot program where qualified external institutions will collaborate with sponsors to develop and review protocols for first-in-human (FIH) clinical trials intended for investigational new drug (IND) submissions to FDA. The two key initiatives were announced as part of a broader program by the…
TETmedical Receives FDA Breakthrough Device Designation for NSE-FAST®, the First Rapid Test Designed to Aid in the Diagnosis of Acute Ischemic Stroke
The FDA granted Breakthrough Device Designation to NSE-FAST® (Neuron Specific Enolase – Functional Activity Stroke Test), a rapid blood test from TETmedical, Inc. positioning them as the first rapid test to aid in diagnosing acute ischemic stroke.Stroke is the #1 condition tied to serious misdiagnosis harm in U.S. emergency departments with roughly 17% of strokes…
LIFE SCIENCES IN NEW YORK
Where science and opportunity come together
New York’s life science sector has attracted unprecedented investment, expanded research clusters across the state, and nurtured the growth of early-stage companies.
#2
NATIONAL R&D SPEND
100,000+
LIFE SCIENCES JOBS
25%
CLINICAL TRIALS IN THE U.S.